These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Association of coagulation factor VII with the risk of myocardial infarction in the Chinese. Cai Q, Chen J, Ma H, Song J, Xu M. Chin Med J (Engl); 2000 Dec; 113(12):1059-63. PubMed ID: 11776135 [Abstract] [Full Text] [Related]
4. Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis. Bozzini C, Girelli D, Bernardi F, Ferraresi P, Olivieri O, Pinotti M, Martinelli N, Manzato F, Friso S, Villa G, Pizzolo F, Beltrame F, Corrocher R. Thromb Haemost; 2004 Sep; 92(3):541-9. PubMed ID: 15351850 [Abstract] [Full Text] [Related]
5. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years. Rallidis LS, Politou M, Komporozos C, Panagiotakos DB, Belessi CI, Travlou A, Lekakis J, Kremastinos DT. Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512 [Abstract] [Full Text] [Related]
12. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Chiappelli M, Tampieri C, Tumini E, Porcellini E, Caldarera CM, Nanni S, Branzi A, Lio D, Caruso M, Hoffmann E, Caruso C, Licastro F. Int J Immunogenet; 2005 Dec; 32(6):349-53. PubMed ID: 16313298 [Abstract] [Full Text] [Related]
15. [Study on plasma coagulation factor VII (FVII) levels and polymorphisms of FVII gene in patients with coronary heart disease]. Kang W, Wang H, Xiong L, Wang X, Chu H, Qu B, Liu X, Yin J, Duan B, Yu J, Wang Z. Zhonghua Xue Ye Xue Za Zhi; 2002 Sep; 23(9):457-9. PubMed ID: 12482354 [Abstract] [Full Text] [Related]
17. Genetic risk factors in myocardial infarction at young age. Incalcaterra E, Hoffmann E, Averna MR, Caimi G. Minerva Cardioangiol; 2004 Aug; 52(4):287-312. PubMed ID: 15284679 [Abstract] [Full Text] [Related]
18. Genetic modulation of coagulation factor VII plasma levels: contribution of different polymorphisms and gender-related effects. Di Castelnuovo A, D'Orazio A, Amore C, Falanga A, Kluft C, Donati MB, Iacoviello L. Thromb Haemost; 1998 Oct; 80(4):592-7. PubMed ID: 9798976 [Abstract] [Full Text] [Related]
20. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde. Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ, Humphries SE, Evans A, Luc G, Cambou JP. Thromb Haemost; 1995 Sep; 74(3):837-41. PubMed ID: 8571307 [Abstract] [Full Text] [Related] Page: [Next] [New Search]